Xiaoyin Qiao1, Yikun Yang1, Ruiying Huang1, Xuelei Shi1, Haoxiang Chen1, Jian Wang1, Yanxiang Chen2, Yongjun Tan1, Zhikai Tan3,4. 1. College of Biology, Hunan University, Changsha, 410082, Hunan, China. 2. Department of Obstetrics and Gynecology, Renmin Hospital, Wuhan University, Wuhan, 430060, Hubei, China. ppfff365@163.com. 3. College of Biology, Hunan University, Changsha, 410082, Hunan, China. tanzk@hnu.edu.cn. 4. Shenzhen Institute, Hunan University, Shenzhen, 518000, Guangdong, China. tanzk@hnu.edu.cn.
Abstract
PURPOSE: Combination chemotherapy is gradually receiving more attention because of its potential synergistic effect and reduced drug doses in clinical application. However, how to precisely control drug release dose and time using vehicles remains a challenge. This work developed an efficient drug delivery system to combat breast cancer, which can enhance drug effects despite reducing its concentration. METHODS: Controlled-release poly-lactic-co-glycolic acid (PLGA) scaffolds were fabricated by E-jet 3D printing to deliver doxorubicin (DOX) and cisplatin (CDDP) simultaneously. RESULTS: This drug delivery system allowed the use of a reduced drug dosage resulting in a better effect on the human breast cancer cell apoptosis and inhibiting tumor growth, compared with the effect of each drug and the two drugs administrated without PLGA scaffolds. Our study suggested that DOX-CDDP-PLGA scaffolds could efficiently destroy MDA-MB-231 cells and restrain tumor growth. CONCLUSIONS: The 3D printed PLGA scaffolds with their time-programmed drug release might be useful as a new multi-drug delivery vehicle in cancer therapy, which has a potential advantage in a long term tumor cure and prevention of tumor recurrence.
PURPOSE: Combination chemotherapy is gradually receiving more attention because of its potential synergistic effect and reduced drug doses in clinical application. However, how to precisely control drug release dose and time using vehicles remains a challenge. This work developed an efficient drug delivery system to combat breast cancer, which can enhance drug effects despite reducing its concentration. METHODS: Controlled-release poly-lactic-co-glycolic acid (PLGA) scaffolds were fabricated by E-jet 3D printing to deliver doxorubicin (DOX) and cisplatin (CDDP) simultaneously. RESULTS: This drug delivery system allowed the use of a reduced drug dosage resulting in a better effect on the humanbreast cancer cell apoptosis and inhibiting tumor growth, compared with the effect of each drug and the two drugs administrated without PLGA scaffolds. Our study suggested that DOX-CDDP-PLGA scaffolds could efficiently destroy MDA-MB-231 cells and restrain tumor growth. CONCLUSIONS: The 3D printed PLGA scaffolds with their time-programmed drug release might be useful as a new multi-drug delivery vehicle in cancer therapy, which has a potential advantage in a long term tumor cure and prevention of tumor recurrence.
Entities:
Keywords:
E-jet 3D printing; cisplatin; combination chemotherapy; controlled release; doxorubicin
Authors: Emmanuel Gyan; Charles Foussard; Philippe Bertrand; Patrick Michenet; Steven Le Gouill; Christian Berthou; Hervé Maisonneuve; Vincent Delwail; Rémi Gressin; Philippe Quittet; Jean-Pierre Vilque; Bernard Desablens; Jérôme Jaubert; Jean-François Ramée; Nina Arakelyan; Antoine Thyss; Cécile Moluçon-Chabrot; Roselyne Delépine; Noël Milpied; Philippe Colombat; Eric Deconinck Journal: Blood Date: 2008-10-27 Impact factor: 22.113
Authors: Y Takei; S Okamoto; K Kawamura; Y Jiang; T Morinaga; M Shingyoji; I Sekine; S Kubo; Y Tada; K Tatsumi; H Shimada; K Hiroshima; N Yamaguchi; M Tagawa Journal: Cancer Gene Ther Date: 2015-08-07 Impact factor: 5.987
Authors: Sepehr Talebian; In Kyong Shim; Javad Foroughi; Gorka Orive; Kara L Vine; Song Cheol Kim; Gordon G Wallace Journal: Polymers (Basel) Date: 2021-12-13 Impact factor: 4.329